{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:31:48Z","timestamp":1781638308266,"version":"3.54.5"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00c3\u00a7\u00c3\u00a3o de Aperfei\u00c3\u00a7oamento de Pessoal de N\u00c3vel Superior","doi-asserted-by":"publisher","award":["88881.859210\/2023-01"],"award-info":[{"award-number":["88881.859210\/2023-01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disorder caused by a deficiency of a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13). The recognition of increased morbidity and mortality in patients after recovery suggests that TTP may become a chronic disease with possible multiple adverse outcomes throughout life. Neurological disorders may occur in the acute phase of TTP due to several pathophysiological mechanisms. These mechanisms include the formation of microvascular thrombosis in capillaries or small arteries of the central nervous system (CNS), leading to transient or permanent ischemic brain damage. However, the causes underlying chronic neurological involvement in TTP are not fully understood, particularly in long-term survivors. Therefore, the aim of this study is to evaluate brain volumetry in TTP patients in remission and to correlate it with the neurological involvement associated with the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>The study cohort includes 16 consecutive patients diagnosed with TTP between 1995 and 2016 at the Hospital de Clinicas, Universidade Estadual de Campinas (HC-UNICAMP), in Brazil. We performed MRI of the patients\u2019 skull. Brain volume and parts of the central nervous system were analyzed and segmented using FreeSurfer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The CNS volumetry of 16 TTP survivors was analyzed and compared with that of 20 age- and sex-matched controls. TTP survivors showed a reduction in intracranial volume (1,019 cubic liters (L\n                      <jats:sup>3<\/jats:sup>\n                      )) compared to the control group (1,280\u2009L\n                      <jats:sup>3<\/jats:sup>\n                      ), with a P value of 0.0003. The nucleus accumbens showed a significant reduction on the left side (469\u2009mm\n                      <jats:sup>3<\/jats:sup>\n                      in TTP survivors X 605\u2009mm\n                      <jats:sup>3<\/jats:sup>\n                      in controls, P\u2009=\u20090.02). The cerebellar cortex showed a reduction on the right side (44176.50\u2009mm\n                      <jats:sup>3<\/jats:sup>\n                      in TTP survivors X 47283.15\u2009mm\n                      <jats:sup>3<\/jats:sup>\n                      in control group, P\u2009=\u20090.05) and on the left side.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study demonstrated a significant reduction in brain and nucleus accumbens volume in patients with TTP compared with a healthy control group. These findings suggest a possible lasting impact of TTP on the CNS and highlight the importance of continued monitoring and intervention to reduce neurological complications in patients after the acute phase of the disease. Future studies are needed to validate our results and elucidate the mechanisms underlying the brain changes observed in patients with TTP. Our findings provide valuable information for developing more effective treatment strategies and improving the quality of life of patients with TTP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0334903","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:36:21Z","timestamp":1762367781000},"page":"e0334903","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Brain volumetric reductions in patients with thrombotic thrombocytopenic purpura"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6009-8607","authenticated-orcid":true,"given":"Jos\u00e9 Thiago de Souza","family":"de Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Appenzeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia","family":"Rittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diedre Santos","family":"do Carmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7908-9073","authenticated-orcid":true,"given":"Fernanda A.","family":"Orsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"8","key":"pone.0334903.ref001","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood.V91.8.2839.2839_2839_2846","article-title":"Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura","volume":"91","author":"M Furlan","year":"1998","journal-title":"Blood"},{"issue":"4","key":"pone.0334903.ref002","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.hoc.2007.06.003","article-title":"Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency","volume":"21","author":"H-M Tsai","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"pone.0334903.ref003","first-page":"393","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura","volume":"325","author":"GA Rock","year":"1991","journal-title":"Mass Med Soc"},{"issue":"13","key":"pone.0334903.ref004","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood.2019001056","article-title":"Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors","volume":"134","author":"H Upreti","year":"2019","journal-title":"Blood"},{"issue":"1","key":"pone.0334903.ref005","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1182\/asheducation-2018.1.548","article-title":"TTP: long-term outcomes following recovery","volume":"2018","author":"JN George","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"12","key":"pone.0334903.ref006","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1182\/blood-2013-04-496752","article-title":"Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura","volume":"122","author":"CC Deford","year":"2013","journal-title":"Blood"},{"issue":"12","key":"pone.0334903.ref007","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/ajh.26341","article-title":"Major adverse cardiovascular events in survivors of immune-mediated thrombotic thrombocytopenic purpura","volume":"96","author":"MA Brodsky","year":"2021","journal-title":"Am J Hematol"},{"issue":"4","key":"pone.0334903.ref008","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1182\/bloodadvances.2020004169","article-title":"Cardiovascular disease is a leading cause of mortality among TTP survivors in clinical remission","volume":"6","author":"S Sukumar","year":"2022","journal-title":"Blood Adv"},{"issue":"10","key":"pone.0334903.ref009","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/WNR.0000000000001915","article-title":"Atrophy of bilateral nucleus accumbens in melancholic depression","volume":"34","author":"Z Chu","year":"2023","journal-title":"Neuroreport"},{"issue":"6","key":"pone.0334903.ref010","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1537-2995.2009.02101.x","article-title":"Cognitive deficits after recovery from thrombotic thrombocytopenic purpura","volume":"49","author":"AS Kennedy","year":"2009","journal-title":"Transfusion"},{"issue":"5","key":"pone.0334903.ref011","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/trf.14060","article-title":"Depression and cognitive deficits as long-term consequences of thrombotic thrombocytopenic purpura","volume":"57","author":"T Falter","year":"2017","journal-title":"Transfusion"},{"issue":"8","key":"pone.0334903.ref012","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ajh.24060","article-title":"Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura","volume":"90","author":"B Han","year":"2015","journal-title":"Am J Hematol"},{"issue":"1","key":"pone.0334903.ref013","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1537-2995.2008.01938.x","article-title":"Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura","volume":"49","author":"QF Lewis","year":"2009","journal-title":"Transfusion"},{"issue":"10","key":"pone.0334903.ref014","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/bloodadvances.2017005124","article-title":"Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015","volume":"1","author":"EE Page","year":"2017","journal-title":"Blood Adv"},{"issue":"9","key":"pone.0334903.ref015","article-title":"Neurological manifestations in thrombotic microangiopathy: Imaging features, risk factors and clinical course","volume":"17","author":"S de Castro JT de","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"pone.0334903.ref016","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.0b013e3181aaea1b","article-title":"Brain lesions are most often reversible in acute thrombotic thrombocytopenic purpura","volume":"73","author":"TM Burrus","year":"2009","journal-title":"Neurology"},{"issue":"5","key":"pone.0334903.ref017","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4065\/mcp.2009.0590","article-title":"Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings","volume":"85","author":"JE Fugate","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"pone.0334903.ref018","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/omcr\/omv001","article-title":"Thrombotic thrombocytopenic purpura with concomitant small- and large-vessel thrombosis, atypical posterior reversible encephalopathy syndrome and cerebral microbleeds","volume":"2015","author":"WL Yu","year":"2015","journal-title":"Oxford Med Case Rep"},{"issue":"1","key":"pone.0334903.ref019","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000513574","article-title":"Identification of Biomarkers in Patients with Thrombotic Thrombocytopenic Purpura Presenting with Large and Small Ischemic Stroke","volume":"11","author":"C Lin","year":"2021","journal-title":"Cerebrovasc Dis Extra"},{"issue":"01","key":"pone.0334903.ref020","article-title":"Cerebral Infarction in Immune Thrombotic Thrombocytopenic Purpura Is Associated with Old Age, Hypertension, Smoking, and Anti-ADAMTS13 Ig, But Not with Mortality","volume":"05","author":"R Memon","year":"2021","journal-title":"TH Open"},{"issue":"5","key":"pone.0334903.ref021","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/bjh.17126","article-title":"Cerebral MRI findings predict the risk of cognitive impairment in thrombotic thrombocytopenic purpura","volume":"191","author":"F Alwan","year":"2020","journal-title":"Br J Haematol"},{"key":"pone.0334903.ref022","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood.2022016044","article-title":"Prevalence of neuropsychiatric complications in thrombotic thrombocytopenic purpura","volume":"7","author":"A Borogovac","year":"2022","journal-title":"Blood"},{"issue":"1","key":"pone.0334903.ref023","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ajh.21881","article-title":"Evidence of persistent neurologic injury following thrombotic thrombocytopenic purpura","volume":"86","author":"SR Cataland","year":"2011","journal-title":"Am J Hematol"},{"issue":"9","key":"pone.0334903.ref024","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1055\/s-0043-1772601","article-title":"Sjogren-Larsson syndrome brain volumetric reductions demonstrated with an automated software","volume":"81","author":"de Castro JT de S","year":"2023","journal-title":"Arq Neuropsiquiatr"},{"issue":"4","key":"pone.0334903.ref025","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study","volume":"4","author":"PK Bendapudi","year":"2017","journal-title":"Lancet Haematol"},{"key":"pone.0334903.ref026","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.artmed.2016.09.001","article-title":"A review on brain structures segmentation in magnetic resonance imaging","volume":"73","author":"S Gonz\u00e1lez-Vill\u00e0","year":"2016","journal-title":"Artif Intell Med"},{"issue":"2","key":"pone.0334903.ref027","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","article-title":"FreeSurfer","volume":"62","author":"B Fischl","year":"2012","journal-title":"Neuroimage"},{"issue":"1","key":"pone.0334903.ref028","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/jth.13882","article-title":"External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment","volume":"16","author":"A Li","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"1","key":"pone.0334903.ref029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12185-009-0476-1","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"91","author":"H-M Tsai","year":"2010","journal-title":"Int J Hematol"},{"issue":"22","key":"pone.0334903.ref030","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"HM Tsai","year":"1998","journal-title":"N Engl J Med"},{"issue":"12","key":"pone.0334903.ref031","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1177\/0961203316643598","article-title":"Posterior reversible encephalopathy syndrome and association with systemic lupus erythematosus","volume":"25","author":"T Ferreira","year":"2016","journal-title":"Lupus"},{"key":"pone.0334903.ref032","doi-asserted-by":"crossref","DOI":"10.3171\/foc.2003.15.4.3","article-title":"Spontaneous intracerebral hemorrhage due to coagulation disorders","volume":"15","author":"AG Quinones-Hinojosa","year":"2003","journal-title":"Neurosurg Focus"},{"issue":"2","key":"pone.0334903.ref033","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/hbm.22194","article-title":"A meta-analysis of cerebellar contributions to higher cognition from PET and fMRI studies","volume":"35","author":"K-H E","year":"2014","journal-title":"Hum Brain Mapp"},{"issue":"4","key":"pone.0334903.ref034","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00429-016-1317-7","article-title":"Regional cerebellar volumetric correlates of manual motor and cognitive function","volume":"222","author":"V Koppelmans","year":"2017","journal-title":"Brain Struct Funct"},{"issue":"2","key":"pone.0334903.ref035","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.neuroimage.2011.08.065","article-title":"Functional topography of the cerebellum for motor and cognitive tasks: an fMRI study","volume":"59","author":"CJ Stoodley","year":"2012","journal-title":"Neuroimage"},{"issue":"1","key":"pone.0334903.ref036","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12311-013-0511-x","article-title":"Consensus paper: the cerebellum\u2019s role in movement and cognition","volume":"13","author":"LF Koziol","year":"2014","journal-title":"Cerebellum"},{"issue":"2","key":"pone.0334903.ref037","first-page":"17","article-title":"Nucleus accumbens atrophy in Parkinson\u2019s disease (Mavridis\u2019 atrophy): 10 years later","volume":"11","author":"IN Mavridis","year":"2022","journal-title":"Am J Neurodegener Dis"},{"issue":"1","key":"pone.0334903.ref038","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/13872877251313816","article-title":"Differences in brain volume in individuals with mild cognitive impairment and normal cognition across different anatomical regions: The Atherosclerosis Risk in Communities (ARIC) study","volume":"104","author":"F Mijares Diaz","year":"2025","journal-title":"J Alzheimers Dis"},{"key":"pone.0334903.ref039","article-title":"Association between Nucleus Accumbens Volume and Substance Use Disorder: A Narrative Review","author":"CL Pimentel \u00c9 de","year":"2025","journal-title":"Trends Psychiatry Psychother"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0334903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:36:27Z","timestamp":1762367787000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0334903"}},"subtitle":[],"editor":[{"given":"Mehmet","family":"Baysal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0334903","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]}}}